H.W.H.M. van der Putten

Author

Also Known As

H. W. H. M. van der Putten, H.W.H.M van der Putten, H.W.H.M. v.d. Putten, H.W.H.M. van der Putten, Hans W. H. M. van der Putten, Hans W.H.M. van der Putten

Publications

566

Citations

H-Index

Concepts

All Affiliations

Maastricht University Medical Centre Maastricht University Elisabeth-TweeSteden Ziekenhuis Radboud University Nijmegen Radboud University Medical Center

About

H.W.H.M. van der Putten is an author at Maastricht University Medical Centre specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	498
2	Public Health	4	4	222
3	Cell Biology	1	1	32
4	Endocrinology	1	1	47
5	Epidemiology	1	1	44

H.W.H.M. van der Putten

Publications

513

Citations

H-Index

Page 1

	Year	Citations
Tumor angiogenesis: An independent prognostic parameter in cervical cancer Gérard L. Bremer, A.T.M.G. Tiebosch, H.W.H.M. van der Putten, American Journal of Obstetrics and Gynecology Cervical CancerMedicinePathologyPublic HealthOncology	1996	96
Assessment of the Risk on Endometrial Cancer in Hyperplasia, by Means of Morphological and Morphometrical Features Jan P. A. Baak, E.C.M. Wisse-Brekelmans, J.C. Fleege, Pathology - Research and Practice InfertilityTumoral PathologyGynecological SurgeryMorphometrical FeaturesPathology	1992	86
Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma H.W.H.M. van der Putten, Jan P. A. Baak, Ton J. M. Koenders, Cancer Prognostic BiomarkersIndividual PatientsOncologyProgesterone ReceptorMedicine	1989	62
Adnexal Masses in Pregnancy Ralph H.M. Hermans, D.-C. Fischer, H.W.H.M. van der Putten, Oncology Research and Treatment Reproductive HealthFetal MedicineGynecologyAdnexal MassesSurgery	2003	52
Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study R. F. M. Vermeulen, Marc van Beurden, Jacobien M. Kieffer, European Journal of Cancer Hormonal ContraceptiveReproductive HealthGynecologyMenopausal Hormone TherapyWomen's Health	2017	47
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986–1996 J.M. de Rijke, H.W.H.M. van der Putten, Ludy Lutgens, European Journal of Cancer Cervical Cancer ScreeningCervical Cancer ManagementCervical CancerCervical HealthMedicine	2002	44
p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis Gérard L. Bremer, Anton T.M.G. Tieboschb, H.W.H.M. van der Putten, European Journal of Obstetrics & Gynecology and Reproductive Biology OncologyCervical CancerMedicinePathologyTumor Suppressor	1995	32
Early stage cervical cancer: aborted versus completed radical hysterectomy Gérard L. Bremer, H.W.H.M. van der Putten, G.A.J. Dunselman, European Journal of Obstetrics & Gynecology and Reproductive Biology Gynecologic SurgerySurgical OncologyCervical Cancer ManagementCervical CancerCervical Health	1992	30
Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation? Carlo Marcelis, H.W.H.M. van der Putten, Carli Tops, Familial Cancer MedicineGynecologyPathologyCancer TreatmentOncology	2001	21
Five Different Histological Subtypes of Germ Cell Malignancies in an XY Female Gérard L. Bremer, J. A. Land, A.T.M.G. Tiebosch, Gynecologic Oncology Different Histological SubtypesGerm CellMalignant DiseasePathogenesisHistopathology	1993	17

Page 1